NeuroSense Therapeutics announces special shareholder meeting
NRSN•Special shareholder meeting scheduled for Aug. 26, 2026
- NeuroSense Therapeutics will hold a special shareholder meeting in Ra’anana, Israel on Aug. 26, 2026.
- Shareholders will vote on authorizing the board to implement one or more reverse share splits within a 1-for-4 to 1-for-40 range.
- The board would set the final ratio and timing within 12 months of the meeting.
